Operating
Change in Other Assets
Eli Lilly Change in Other Assets remained flat by 0.0% to $1.65B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 98.4%, from $832.75M to $1.65B. Over 4 years (FY 2021 to FY 2025), Change in Other Assets shows an upward trend with a 44.5% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
Large fluctuations may indicate changes in corporate strategy, such as significant prepayments for future services or shifts in deferred tax assets.
Detailed definition
This captures the net change in miscellaneous assets that do not fall under standard working capital categories like rec...
Peer comparison
Varies widely based on accounting practices and business complexity.
Metric ID:
change_in_other_assetsHistorical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | -$1.52B | $793.50M | $3.45B | $3.33B | $6.61B |
| YoY Change | — | +152.4% | +335.2% | -3.5% | +98.4% |
Range-$1.52B – $6.61B
CAGR+44.5%
Avg YoY Growth+145.6%
Median YoY Growth+125.4%
Change in Other Assets at Other Companies
Frequently Asked Questions
- What is Eli Lilly's change in other assets?
- Eli Lilly (LLY) reported change in other assets of $1.65B in Q4 2025.
- How has Eli Lilly's change in other assets changed year-over-year?
- Eli Lilly's change in other assets increased by 98.4% year-over-year, from $832.75M to $1.65B.
- What is the long-term trend for Eli Lilly's change in other assets?
- Over 4 years (2021 to 2025), Eli Lilly's change in other assets has grown at a 44.5% compound annual growth rate (CAGR), from -$1.52B to $6.61B.
- What does change in other assets mean?
- The change in miscellaneous short-term assets not classified as inventory or receivables.